Literature DB >> 10742419

Clinicopathologic study of ectomesenchymomas from Intergroup Rhabdomyosarcoma Study Groups III and IV.

D R Boué1, D M Parham, B Webber, W M Crist, S J Qualman.   

Abstract

Ectomesenchymomas (EM) are rare malignant neoplasms usually consisting of rhabdomyosarcoma (RMS) with a neural component. Only 21 cases have been previously reported. Here we extend the clinicopathologic spectrum of EM by describing our findings in 15 cases. Only 5 patients were infants; 10 were < or =3 years old and 5 were > or =6 years old. No male predilection was observed; 7 were female. The originating institutional diagnoses were; RMS (12), undifferentiated sarcoma (1), or EM (2), suggesting underdiagnosis of this entity. The primary tumor sites included external genital (5), pelvis/abdomen (6), head and neck (3), and extremity (1). The size of the primary neoplasm was usually > or =5 cm at diagnosis but dissemination only occurred in a minority. Local infiltration was not uncommon. These neoplasms were typically multilobate, thinly encapsulated, hemorrhagic, and necrotic. Light microscopic features were highly variable, but embryonal RMS with scattered or clustered ganglion cells, often in lacunae, was characteristic. In some cases, primitive neuroblastic or neuroectodermal areas were found and/or a component of alveolar RMS was seen. Focal anaplasia was occasionally observed. Mitotic activity appears higher than previously appreciated and some necrosis was invariably present. Electron microscopy was performed in 11 cases, which confirmed skeletal muscle +/- neural differentiation. Cytogenetic studies performed in five cases revealed no specific abnormality. Monoclonal neuron-specific enolase was the best marker of ganglion cells and primitive neural elements. MIC-2 (CD99) membrane expression was not definitively present in any of the six cases examined. A number of the above parameters appear to be of some prognostic significance, but overall, these neoplasms appear to have a similar outcome as would be predicted for their RMS element alone (exclusive of any neural component), with respect to the RMS subtype, age of the patient, and anatomic location of the neoplasm.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10742419     DOI: 10.1007/s100249910039

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  6 in total

Review 1.  Ewing sarcoma/peripheral primitive neuroectodermal tumor and related tumors.

Authors:  Maria Tsokos; Rita D Alaggio; Louis P Dehner; Paul S Dickman
Journal:  Pediatr Dev Pathol       Date:  2012

Review 2.  Risk assignment in pediatric soft-tissue sarcomas: an evolving molecular classification.

Authors:  Stephen J Qualman; Raffaella A Morotti
Journal:  Curr Oncol Rep       Date:  2002-03       Impact factor: 5.075

3.  Frequent HRAS Mutations in Malignant Ectomesenchymoma: Overlapping Genetic Abnormalities With Embryonal Rhabdomyosarcoma.

Authors:  Shih-Chiang Huang; Rita Alaggio; Yun-Shao Sung; Chun-Liang Chen; Lei Zhang; Yu-Chien Kao; Narasimhan P Agaram; Leonard H Wexler; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2016-07       Impact factor: 6.394

4.  Pathobiologic markers of the ewing sarcoma family of tumors: state of the art and prediction of behaviour.

Authors:  Alfredo Pinto; Paul Dickman; David Parham
Journal:  Sarcoma       Date:  2010-10-14

5.  Epidemiological characteristics and survival studies of rhabdomyosarcoma in East egypt: a five-year multicenter study.

Authors:  M A Badr; Y A Al-Tonbary; A K Mansour; T H Hassan; M R Beshir; A Darwish; R A El-Ashry
Journal:  ISRN Oncol       Date:  2012-05-17

6.  Metastatic malignant ectomesenchymoma initially presenting as a pelvic mass: report of a case and review of literature.

Authors:  A Nael; P Siaghani; W W Wu; K Nael; Lisa Shane; S G Romansky
Journal:  Case Rep Pediatr       Date:  2014-10-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.